Nodal expression in triple-negative breast cancer: Cellular effects of its inhibition following doxorubicin treatment

Triple-negative breast cancer (TNBC) represents an aggressive cancer subtype characterized by the lack of expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). The independence of TNBC from these growth promoting factors eliminates the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Cycle
Autors principals: Bodenstine, Thomas M., Chandler, Grace S., Reed, David W., Margaryan, Naira V., Gilgur, Alina, Atkinson, Janis, Ahmed, Nida, Hyser, Matthew, Seftor, Elisabeth A., Strizzi, Luigi, Hendrix, Mary J. C.
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2016
Matèries:
Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4889232/
https://ncbi.nlm.nih.gov/pubmed/27007464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2016.1160981
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars